Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Goserelin for Preservation of Ovarian Function Following Auto-HSCT
NCT07552493Not yet recruiting
- Start
- May 2026
- Primary completion
- May 2027
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of goserelin (2 arms). Primary endpoint: Menstrual recovery rate at 6 months. Planned start May 2026; status: not yet recruiting.
02
Drugs
goserelin
Beyond the preview
Go deeper on NCT07552493.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07552493.